WRassman,M.D. BaldingBlog
    • Menu

    Since I’m Terrified About What I Read Online, I’m Going to Take 0.25mg Propecia Twice a Week

    Mar 25, 2014/by William Rassman, M.D./6 /Drugs

    I am a 22 year old male who has had thinning hair for almost 5 years and have got to a point where my quality of life has deteriorated, due to this I decided to take the plunge with propecia.I took my first dose of propecia yesterday at 0.25 mg and plan to take this twice a week, every Tuesday and Saturday, having read about success with this regime.

    I know propecia only has a half life of 8-12 hours but it takes the body around a week to start creating the enzyme that creates DHT in the body and studies show that 0.25-0.5 mg has up to 80% success of 1.0 – 5.0mg. This is because I’m terrified of sides on propecia and also I would not be comfortable taking any medication every day of my life. I just wondered what you think of this regime?

    When the Propecia (finasteride) studies were performed that eventually led to the medication’s FDA approval, various doses were tried. The 1mg dose gave the most consistent results for treating hair loss. Above the 1mg daily dose, the results were no better than the 1mg daily dose; however, below the 1mg dose, it was found to be less effective. In your case with taking a 1/4 dose only twice a week, the medication will be out of your system for days at a time, so the benefits might be fairly limited.

    The side effects you are concerned about may happen, but statistically it is a small risk; however, I have found that the risk of sexual side effects increases in those young men who obsess over the possibility of having side effects, somewhat talking themselves into it. It is your call, of course.

    Tags: propecia, finasteride, hairloss, hair loss, side effects

    Reader Comments6

    Share this entry
    • Share on Facebook
    • Share on Twitter
    Newer Entries Older Entries
    1. Paul
      Paul says:
      Mar 25, 2014 at 3:21 pm

      Why don’t you take the actual recommended dose and see if you even experience any side effects? Despite the horror stories only a small minority of men experience any negatives. If you try it at this reduced, unsubstantiated dose you risk getting no benefit for your hair at all.

      If you try it and subsequently have problems you can reduce the dose in a consistent manner until the side effects stop. That’s much more sensible than starting on 1/14th of the proven dose and hoping for the best.

      Reply
    2. HairGuy
      HairGuy says:
      Mar 25, 2014 at 7:37 pm

      The reason why your suggestion is not sensible is the side effects do not always ‘stop’. The FDA didn’t find 1mg to be the most effective dose, in fact the dosage was quite arbitrary. Studies have shown that 0.05mg of Propecia are almost as effective as a full mg which shows you how potent this medication is.

      Reply
    3. BiotechMD
      BiotechMD says:
      Mar 26, 2014 at 12:47 pm

      The regulatory package and studies that formed the basis of Propecia approval in the US for baldness are publicly available at http://www.fda.gov (go to drugs@FDA, then Propecia, then Approval History, then Review, then Medical Review).

      It is obviously not the case that the study of 1 mg dosing was “arbitrary”. Dosing is based on numerous considerations, including nonclinical animal safety and toxicology data, in vitro studies, human pharmacology and pharmacokinetic studies, and initial uncontrolled studies – all summarized in the regulatory application (and scientific literature, also publicly available, at http://www.ncbi.nlm.nih.gov/pubmed). Companies usually don’t put several hundred million dollars into programs and then just randomly come up with a dose to be studied.

      It is also not the case that 0.05 mg is equally effective. In fact, the effectiveness of 0.05 mg wasn’t even studied in any of the clinical studies that supported approval (and included 3217 patients). One of the 13 studies (number 065) that supported approval was a 6-week study of 249 patients equally divided into groups to receive doses of 0.01, 0.05, 0.2, 1, and 5 mg (or placebo) to evaluate the effect of drug on scalp DHT and sebum (a clinical pharmacology study), not to study of efficacy or safety. This study found that men treated for 6 weeks with daily doses ranging from 0.01 to 5 mg had a dose-related decrease in scalp skin and serum DHT levels (lower the dose, lower the levels). But, the effect on DHT in the 1 mg dose group was not that much different from the 5 mg group. This led to the choice of only 1 mg in the phase 3 studies.

      It is naive to think that playing around with different doses without evidence of efficacy based on blog postings is equivalent to data collected on 3217 patients. In the absence of large amounts of data, it’s also incorrect to assume that a lower dose equals lower risk of side effects. Sometimes it does, sometimes it doesn’t. Only 1 mg was assessed in the three phase 3 studies that supported approval.

      The issue of reversibility of side effects is a separate one (and an additional issue that the initial poster has to think about). While there is little clinical trial evidence of irreversibility of sexual side effects with finasteride, many patients anecdotally report this and it is currently being evaluated

      Reply
    4. BiotechMD
      BiotechMD says:
      Mar 26, 2014 at 1:00 pm

      Just for clarity, I recognize that the initial poster was talking about 0.5 finasteride and the answer of another blogger discussed 0.05 (the latter blogger probably meant 0.5). My lengthy response above is the same, whether 0.05 or 0.5 mg. The efficacy of finasteride 0.5 mg was not studied in any of the 13 trials that comprised the Propecia approval. I am also not aware of published controlled safety and efficay studies evaluating this dose for baldness post-approval.

      Reply
    5. Paul
      Paul says:
      Mar 26, 2014 at 5:58 pm

      Well I would respond but looks like biotechMD pretty much answered any questions. Please provide some genuine studies where taking a tiny portion of an effective dose actually does anything.

      Reply
    6. HairGuy
      HairGuy says:
      Mar 26, 2014 at 8:55 pm

      Hi Biotech MD,

      I appreciate your thorough response. I actually meant 0.05mg rather than the 0.5mg you suggested. You seem incredibly knowledgeable about Propecia and very experienced in the pharmaceutical industry. I was referring to a peer-reviewed article that was published by Dr. Frankel in the Journal of Dermatology shortly after Propecia was approved.

      https://www.fda.gov/ohrms/dockets/dailys/00/jun00/060700/cp00001.rtf

      Will you provide your interpretation of his study? I’m looking at figure 1 (which I believe is the study number 065 you mentioned). The data presented shows there is no statistically significant additional reduction of DHT measured in the scalp beyond the 0.05mg level up to 5.0mg. While this isn’t measuring hair count, Propecia preserves hair by reducing DHT so this would directly relate to efficacy.

      There is a second study he references (in table 8.1.2.4.2 which I cannot find) that does show there was a larger mean improvement for 1.0 mg dose of Propecia over the 0.2 mg but the result is not statistically significant since the values overlapped at the 95% confidence interval.

      I would love to hear your explanation of these studies. Since you seem to know so many about Propecia, do you work at Merck or did you in the past or is this an independent interest of yours?

      Reply

    Leave a Comment

    Want to join the discussion? Feel free to contribute! Note: We do not tolerate offensive language or personal attacks to other readers. Marketing links or commercial advertisements will be deleted.

    Leave a Reply Cancel reply

    Your email address will not be published. Required fields are marked *

    ( Will not be published )

    + =

    Videos

    Podcasts

    Ask Dr. Rassman

    * Your questions may be published (without your contact information).

    [contact-form-7 id=”27935″ title=”Sidebar Contact”]

    Over 21 million women and 35 million men in America suffer from hair loss. For many of these people, the psychological impact on their life is debilitating.

    Dr. Rassman is a world leading expert in hair loss with over 25 years of experience and over 50,000 satisfied clients.

    About

    This site exists to educate about hair loss and hair restoration.

    William R. Rassman, M.D.

    Categories

    • ACell
    • African American
    • Age
    • April Fools
    • Density
    • Diseases
    • Drugs
    • Drugs (Cause Hair Loss)
    • Favorites
    • Female Hair Loss
    • FUE
    • Hair Cloning
    • Hair Loss Causes
    • Hair Pieces / Systems
    • Hair Products
    • Hair Transplantation
    • Hairlines
    • Megasession
    • Other
    • Other Surgical Procedures
    • Personal Stories
    • Photos
    • Pigments
    • Podcasts
    • Post-Operative
    • Repair
    • Repost
    • Scalp MicroPigmentation
    • Scarring
    • Thinning
    • Tidbits
    • Training
    • Videos

    Archives

    • December 2023
    • November 2023
    • October 2023
    • September 2023
    • August 2023
    • July 2023
    • June 2023
    • May 2023
    • April 2023
    • March 2023
    • February 2023
    • January 2023
    • December 2022
    • November 2022
    • October 2022
    • September 2022
    • August 2022
    • July 2022
    • June 2022
    • May 2022
    • April 2022
    • March 2022
    • February 2022
    • January 2022
    • December 2021
    • November 2021
    • October 2021
    • September 2021
    • August 2021
    • July 2021
    • June 2021
    • May 2021
    • April 2021
    • March 2021
    • February 2021
    • January 2021
    • December 2020
    • November 2020
    • October 2020
    • September 2020
    • August 2020
    • July 2020
    • June 2020
    • May 2020
    • April 2020
    • March 2020
    • February 2020
    • January 2020
    • December 2019
    • November 2019
    • October 2019
    • September 2019
    • August 2019
    • July 2019
    • June 2019
    • May 2019
    • April 2019
    • March 2019
    • February 2019
    • January 2019
    • December 2018
    • November 2018
    • October 2018
    • September 2018
    • August 2018
    • July 2018
    • June 2018
    • May 2018
    • April 2018
    • March 2018
    • February 2018
    • January 2018
    • December 2017
    • November 2017
    • October 2017
    • September 2017
    • August 2017
    • July 2017
    • June 2017
    • May 2017
    • April 2017
    • March 2017
    • February 2017
    • January 2017
    • December 2016
    • November 2016
    • October 2016
    • June 2016
    • May 2016
    • April 2016
    • March 2016
    • February 2016
    • January 2016
    • December 2015
    • November 2015
    • October 2015
    • September 2015
    • August 2015
    • July 2015
    • June 2015
    • May 2015
    • April 2015
    • March 2015
    • February 2015
    • January 2015
    • December 2014
    • November 2014
    • October 2014
    • September 2014
    • August 2014
    • July 2014
    • June 2014
    • May 2014
    • April 2014
    • March 2014
    • February 2014
    • January 2014
    • December 2013
    • November 2013
    • October 2013
    • September 2013
    • August 2013
    • July 2013
    • June 2013
    • May 2013
    • April 2013
    • March 2013
    • February 2013
    • January 2013
    • December 2012
    • November 2012
    • October 2012
    • September 2012
    • August 2012
    • July 2012
    • June 2012
    • May 2012
    • April 2012
    • March 2012
    • February 2012
    • January 2012
    • December 2011
    • November 2011
    • October 2011
    • September 2011
    • August 2011
    • July 2011
    • June 2011
    • May 2011
    • April 2011
    • March 2011
    • February 2011
    • January 2011
    • December 2010
    • November 2010
    • October 2010
    • September 2010
    • August 2010
    • July 2010
    • June 2010
    • May 2010
    • April 2010
    • March 2010
    • February 2010
    • January 2010
    • December 2009
    • November 2009
    • October 2009
    • September 2009
    • August 2009
    • July 2009
    • June 2009
    • May 2009
    • April 2009
    • March 2009
    • February 2009
    • January 2009
    • December 2008
    • November 2008
    • October 2008
    • September 2008
    • August 2008
    • July 2008
    • June 2008
    • May 2008
    • April 2008
    • March 2008
    • February 2008
    • January 2008
    • December 2007
    • November 2007
    • October 2007
    • September 2007
    • August 2007
    • July 2007
    • June 2007
    • May 2007
    • April 2007
    • March 2007
    • February 2007
    • January 2007
    • December 2006
    • November 2006
    • October 2006
    • September 2006
    • August 2006
    • July 2006
    • June 2006
    • May 2006
    • April 2006
    • March 2006
    • February 2006
    • January 2006
    • December 2005
    • November 2005
    • October 2005
    • September 2005
    • August 2005
    • July 2005
    • June 2005
    • May 2005
    • April 2005
    • June 202
    • May 202

    Links

    Disclaimer

    This site is intended to educate the public on hair loss topics based on personal experience and opinions from Dr. William Rassman and contributing physician editors. Information provided on BaldingBlog.com should not be used for the purpose of medical diagnosis or treatment.

    Scroll to top